NAICS 325412Pharmaceutical Preparation Manufacturing
The Census Bureau's definition, the SBA size standard that decides who is small under it, and the federal market behind it: what the government spends under 325412, the agencies that buy it, the companies that win it and the notices open under it today.
Federal contract obligations
FY 2022 to FY 2027 so far
Top buying department
USAspending.gov
To small businesses
Share of the obligations
Open notices now
SAM.gov, posted under this code
Official definition
Census Bureau, 2022 NAICS, verbatim.
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
Illustrative activities (74)
- Adrenal medicinal preparations manufacturing
- Analgesic preparations manufacturing
- Anesthetic preparations manufacturing
- Angiourographic diagnostic preparations manufacturing
- Antacid preparations manufacturing
- Anthelmintic preparations manufacturing
- Antibacterial preparations manufacturing
- Antibiotic preparations manufacturing
- Antidepressant preparations manufacturing
- Antihistamine preparations manufacturing
- Antineoplastic preparations manufacturing
- Antipyretic preparations manufacturing
- Antiseptic preparations manufacturing
- Antispasmodic preparations manufacturing
- Astringent preparations manufacturing
- Barbiturate preparations manufacturing
- Barium in-vivo diagnostic substances manufacturing
- Belladonna preparations manufacturing
- Birth control pills manufacturing
- Botanical extract preparations (except in-vitro diagnostics) manufacturing
- Cardiac preparations manufacturing
- Cathartic preparations manufacturing
- Central nervous system stimulant preparations manufacturing
- Coagulation in-vivo diagnostic substances manufacturing
- Cold remedies manufacturing
- Contraceptive preparations manufacturing
- Contrast media in-vivo diagnostic substances (e.g., iodine, barium) manufacturing
- Cough drops, medicated, manufacturing
- Cough medicines manufacturing
- Cyclopropane medicinal preparations manufacturing
- Dermatological preparations manufacturing
- Diagnostic biological preparations (except in-vitro) manufacturing
- Dietary supplements, compounded, manufacturing
- Digestive system preparations manufacturing
- Digitalis medicinal preparations manufacturing
- Diuretic preparations manufacturing
- Effervescent salts manufacturing
- Electrolyte in-vivo diagnostic substances manufacturing
- Eye and ear preparations manufacturing
- Fever remedy preparations manufacturing
- Glandular medicinal preparations manufacturing
- Hematology in-vivo diagnostic substances manufacturing
- Herbal supplements, compounded, manufacturing
- Hormone preparations (except in-vitro diagnostics) manufacturing
- Insulin preparations manufacturing
- Intravenous (IV) solution preparations manufacturing
- In-vivo diagnostic substances manufacturing
- Iodinated in-vivo diagnostic substances manufacturing
- Laxative preparations manufacturing
- Lip balms manufacturing
- Metabolite in-vivo diagnostic substances manufacturing
- Mouthwashes, medicated, manufacturing
- Muscle relaxant preparations manufacturing
- Nonprescription drug preparations manufacturing
- Nuclear medicine (e.g., radioactive isotopes) preparations manufacturing
- Oral contraceptive preparations manufacturing
- Patent medicine preparations manufacturing
- Penicillin preparations manufacturing
- Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing
- Pituitary gland preparations manufacturing
- Radioactive in-vivo diagnostic substances manufacturing
- Sedative preparations manufacturing
- Sodium chloride pharmaceutical preparations manufacturing
- Sodium salicylate preparations manufacturing
- Suppositories manufacturing
- Technetium medicinal preparations manufacturing
- Thyroid preparations manufacturing
- Tincture of iodine preparations manufacturing
- Tranquilizer preparations manufacturing
- Vermifuge preparations manufacturing
- Veterinary medicinal preparations manufacturing
- Vitamin preparations manufacturing
- Water (i.e., drinking) decontamination or purification tablets manufacturing
- Zinc oxide medicinal preparations manufacturing
What the manual classifies elsewhere
- Manufacturing uncompounded medicinal chemicals and their derivatives--are classified in U.S. Industry 325411, Medicinal and Botanical Manufacturing;325411
- Manufacturing in-vitro diagnostic substances--are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing; and325413
- Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use)--are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing.325414
Small business size standard
SBA's rule under 13 C.F.R. 121.201, a different authority from the classification.
In force today. 13 C.F.R. 121.201
Proposed rule, 91 FR 53741 (Aug 20, 2026). Comments closed Nov 20, 2026. Not in force until SBA publishes a final rule.
Read the comments on Regulations.govDocket SBA-2026-0199
SBA OHA appeals that cite it
NAICS designation and size appeals whose caption or digest states this code. OHA dockets by case number rather than by industry, so this is a text match on the published text, not a field the corpus stores.
No OHA decision in the corpus names this code.
Who buys it, who wins it
Prime contract obligations under 325412, FY 2022 to FY 2027 so far, live from USAspending.gov. Companies are summed across their registrations.
Obligations by fiscal year
Obligations by fiscal year could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
Agencies that buy it
The agencies that buy this code could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
Who wins it
The companies that win this code could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
What is bought under it
Product and service codes (PSC) on the awards under this industry.
The product and service codes under this industry could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
The largest awards under 325412
Award value to date, from USAspending.gov. Each award opens on USAspending.gov.
The largest awards could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
Open notices under 325412
Contract Opportunities, refreshed daily. Each notice opens on SAM.gov.
- Morphine Sulfate SolutionNo set-asideDue Dec 21, 2026
Defense Logistics Agency
- 6505--VA Loma Linda FDGNo set-asideDue Dec 2, 2026
Department of Veterans Affairs
- RFP - Filgrastim Syringes or BiosimilarNo set-asideDue Dec 9, 2026
Department of Veterans Affairs
- 6505--Nitroglycerin SL Tablets (VA-27-00011802)No set-asideDue Dec 18, 2026
Department of Veterans Affairs
- Charleston CMOP CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15MLSmall Business Set Aside - TotalDue Nov 25, 2026
Department of Veterans Affairs
Search every award under 325412
Filter the prime awards by keyword, agency, company, set-aside, place of performance and fiscal-year window, and download the list.
Every open notice, filtered
All open SAM.gov notices under the code by set-aside, notice type and agency, searchable by keyword.
Where you stand under 325412
Your own awards under the code, your size under its standard, and the open notices matched to your company.
Related industries
NAICS 325412,
answered.
The size standard, the spending and the buyers under Pharmaceutical Preparation Manufacturing, from the figures on this page.
NAICS 325412 is Pharmaceutical Preparation Manufacturing in the 2022 North American Industry Classification System. This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
The SBA size standard for NAICS 325412 is 1,300 employees under 13 C.F.R. 121.201. SBA has proposed 2,350 employees in 91 FR 53741; the proposal is not in force until SBA publishes a final rule.
Work the market under 325412
Rank the buyers and the partners under this code, search its awards and notices, and see where your company stands. Monthly Pro starts with a 14-day free trial.
Sources: U.S. Census Bureau, 2022 NAICS; 13 C.F.R. 121.201; USAspending.gov; SAM.gov Contract Opportunities; SBA Office of Hearings and Appeals. Figures refresh daily. A code and a size standard shown here are research, not a size determination or a NAICS code designation, which only SBA and the contracting officer make. A company or agency listed here is not an endorsement.